JY
The Joint Corp.
JYNT · NASDAQ
$8.43 -1.63% (-$0.14)
1M +2.43%
Market Cap $118.3M
P/E Ratio 31.15x
Div. Yield -
ROE 22.00%
Bulios Fair Price
$7.2
14.6% downside
Current Price
$8.43
Undervalued Fair Value Overvalued
According to Bulios Fair Price, JYNT is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Strong
8/9Valuation
28 /100
Expensive EV/EBITDA 25.58x
P/S 2.02x
P/B 7.46x
Growth
30 /100
Declining Rev. growth 18.46%
FCF growth 47.48%
Book val. growth 22.68%
Profitability
48 /100
Moderate Net margin 6.49%
Op. margin 2.45%
FCF margin 7.22%
Quality
65 /100
Average ROE 22.00%
ROA 7.36%
Asset turnover 1.13x
Debt
98 /100
Low Current ratio 1.83x
Net debt/EBITDA -5.24x
Debt/Equity 0.13x
Stability
28 /100
Unstable Rev. volatility 35.76%
EPS volatility 993.96%
Profitable years 1
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about JYNT
Online
Sector
Healthcare
Industry
Medical - Care Facilities
CEO
Sanjiv Razdan
Employees
330
Headquarters
Scottsdale
Upcoming events
05 NOV
Earnings
Upcoming earnings report